Inflammatory Bowel Disease News

• The Case of the Drunken Teetotaler Episodes of somnolence and lethargy with recurring alcohol intoxication tormented a 50-year-old woman until the diagnosis of the rare auto-brewery syndrome was considered.
  Medscape Medical News, July 23, 2024
• Enhanced Recovery Protocol Boosts Crohn's Surgery Outcomes A perioperative enhanced recovery protocol significantly reduced complications and hospital readmission rates for patients with Crohn's disease who underwent surgical resection.
  Medscape Medical News, July 16, 2024
• A 'Fitbit for the Gut' May Aid in Detection of GI Disorders An AI-enabled system of wearable coils and ingestible "smart" pills shows promise for identifying and tracking gasses in the GI tract associated with digestive disorders.
  Medscape Medical News, July 15, 2024
• Three AI Technologies Poised to Transform IBD Care Experts are optimistic that image analysis, natural language processing, and generative AI will soon become foundational to the management of patients with IBD.
  Medscape Medical News, July 14, 2024
• What to Ask Your Patients With Somatic Symptom Disorder Challenging traditional diagnostic approaches, a recent review revealed that one third of all symptoms lacked identifiable somatic causes.
  Medscape Medical News, July 11, 2024
• D-Day for Vitamin D Disease-Prevention Guideline? A new Endocrine Society guideline to limit vitamin D supplementation to daily recommended intake for all but certain at-risk groups and to avoid routine testing raised hackles among Medscape readers.
  Medscape Medical News, July 10, 2024
• Alert FDA Approves Third Ustekinumab Biosimilar The biosimilar is approved for all indications of the reference medication, Stelara, and will launch in February 2025.
  Medscape Medical News, July 01, 2024
• Immunosuppressives Unlikely to Raise Cancer Risk in IBD The findings add to a growing body of literature supporting the relative safety of immunosuppressive therapy to treat IBD in patients who have a history of cancer.
  Medscape Medical News, June 26, 2024
• Sonelokimab Yields Significant Improvements in Active PsA Patients receiving sonelokimab experienced higher treatment response in ACR20, ACR50, and PASI90 than those in the placebo group.
  Medscape Medical News, June 25, 2024
• Alert FDA Approves Skyrizi for Ulcerative Colitis The approval is the fourth indication for the anti–interleukin 23 monoclonal antibody after approval for Crohn's disease, psoriatic arthritis, and plaque psoriasis.
  Medscape Medical News, June 19, 2024
• EULAR 2024 Izokibep Enthesitis Benefit Lacking in Phase 2b/3 PsA Trial The primary efficacy endpoint was met, but the novel small molecule therapeutic did not reduce enthesitis more than placebo, as might have been expected.
  Medscape Medical News, June 19, 2024
• Diet Conditioning Before FMT Improves Outcomes in UC Patients with UC who received FMT from diet-preconditioned donors, and followed a healthy diet themselves, experienced superior microbial benefits.
  Medscape Medical News, June 13, 2024
• Can Chemical Agents and Pollens Induce Food Allergies? Few studies have been conducted on the potential links between various irritants and food allergies.
  Medscape Medical News, June 12, 2024
• The 'Useless' Appendix Is More Fascinating Than We Thought It turns out the appendix, as easy to dismiss as it is to remove, may have a vital purpose after all, including protecting us from gastrointestinal and other diseases.
  Medscape Medical News, June 10, 2024
• ASCO 2024 CAR T for B-ALL: Game Changer for Young Patients? New data indicate that the CAR-T cell agent tisagenlecleucel can improve outcomes in young patients with relapsed/refractory B-cell acute lymphoblastic leukemia.
  MDedge News, June 07, 2024
• Genetic Research Points Toward Possible New IBD Treatments Symptoms of IBD include persistent diarrhea, abdominal pain, rectal bleeding, or bloody stools, as well as weight loss and fatigue.
  WebMD Health News, June 07, 2024
• DDW 2024 Microbiota-Focused Dietary Therapy Could Improve MASLD Emerging evidence supports dietary modulation via the gut-liver axis in the management of patients with metabolic dysfunction-associated steatotic liver disease.
  MDedge News, June 06, 2024
• Medicare Part D Plans Poorly Cover Adalimumab Biosimilars This narrow coverage limits the cost-saving potential of these biosimilar competitors, expert said.
  Medscape Medical News, June 06, 2024
• Alert FDA Extends Upadacitinib Indications to Kids With Arthritis The JAK inhibitor's safety profile for patients as young as 2 years was similar to known to the known safety profile in adults.
  Medscape Medical News, June 04, 2024
• ENDO 2024 'Don't Screen' for Vitamin D: New Endo Society Guideline In its new evidence-based clinical practice guideline, the Endocrine Society recommends against routine 25(OH)D testing in the absence of indications and limiting vitamin D supplementation.
  Medscape Medical News, June 03, 2024